Skip to content

Independent FDA inspection consulting

  • Helping regulated businesses since 2000
  • Urgent FDA help: (888) 781-1822
  • Email us
Login Create Account
FDA Inspection Alerts
FDA Inspection Alerts
FDA Inspections
Services⌄

Inspection & response

  • Inspection readiness
  • Mock inspections & GMP benchmarking
  • FDA 483 response
  • Warning Letter remediation
  • Laboratory inspection support

Quality & leadership

  • Fractional QA & management
  • Vendor & supplier qualification
  • Facility acquisition audits
  • Board & executive advisory
  • Virtual consulting
  • Team training
Industries⌄

Life sciences

  • Pharmaceuticals
  • Biologics
  • Medical devices
  • IVD / diagnostics
  • Laboratories
  • Clinical Trials & Research

Specialized products

  • Radiation-emitting products
  • Combination products
  • Contract laboratories

Consumer products

  • Tobacco products
  • Food
  • Dietary supplements
  • Cosmetics
  • Animal food & health
Insights⌄

Reviews & updates

  • Weekly reviews
  • Monthly reviews
  • Latest articles
  • FDA Inspection Alerts

Boards & business decisions

  • Quality leadership articles
  • Board updates during an inspection
  • Buying a regulated business
  • How fractional QA works

Research

  • Investigator & inspection search
  • Public-record case notes
  • Weekly podcast
Immersive Inspections⌄

Learn & practice

  • Explore immersive inspections
  • Inspection guides
  • Virtual walkthroughs
  • Contract laboratory edition

Read & discuss

  • In the Warroom: stories & case studies
  • Join the reading club
  • Contribute a story
Resources⌄

Tools & learning

  • Free inspection templates
  • Store
  • Training for teams
  • FDA committees & courses
  • All resources

Community

  • Community overview
  • Member dashboard
  • Questions & forums
  • Member profiles
  • Careers & job postings
  • Former FDA contributors

Company

  • About Us
  • Press Room
  • Join Us
  • Sponsorships & partnerships
  • Contact Us
Events⌄

Calendar & training

  • FDA events calendar
  • Webinars, courses & conferences
  • Planned programs & signups
  • Inspection training

Community sessions

  • Reading club
  • Podcast launch
  • Customized company programs
Contact Us

FDA compliance for boards, investors & business decisions

Connect quality evidence with a business decision. These independent articles explain practical questions without certifying a company’s compliance or predicting an inspection outcome.

  • What to tell your board while an FDA inspection is ongoing
  • How to teach your board about GMP and FDA compliance
  • How to talk to investors about FDA compliance
  • How to explain an FDA inspection to your board or investors
  • How fractional QA works in a regulated business
  • What to tell your vendors during an FDA inspection
  • Why did we receive a Form 483 after passing an ISO audit?
  • Radiation-emitting product records: where inspection preparation starts
  • Tobacco manufacturing compliance: build a product and record map
  • Clinical trial inspection preparation: who can retrieve the source record?

Buying an FDA-regulated business: assess compliance risk · Building a new facility · Board advisory · Acquisition audits

Keep exploring: Inspection preparation

Read & practice
  • Related short preparation guides
  • In the Warroom: industry chapters & cases
  • Virtual inspection practice
Discuss & learn with others
  • Explore proposed webinars & courses
  • Industry reading-club interests
  • Vote for your next topic
  • Customize training for your company

FDA Inspections

FDA inspection readiness, Form 483 response support, and urgent consulting from former FDA investigators.

  • (888) 781-1822
  • Email us

Services

  • Inspection readiness
  • Fractional QA & management
  • Laboratory inspection support
  • GMP audits & benchmarking
  • Vendor & supplier qualification
  • Facility acquisition audits
  • Board advisory
  • Form 483 response
  • Warning Letter remediation
  • Team training

Industries

  • Pharmaceuticals
  • Medical Devices
  • IVD / Diagnostics
  • Biologics
  • Food
  • Dietary Supplements
  • Cosmetics
  • Animal Food & Health
  • Clinical Trials & Research
  • Radiation-emitting products
  • Tobacco products
  • Combination products

Company

  • About Us
  • Press Room
  • Join Us
  • Sponsorships & partners
  • Community & forums
  • Contact Us

Subscribe to FDA Inspection Alerts

Get expert insights, regulatory updates, and inspection tips delivered straight to your inbox. No spam. Unsubscribe anytime.

© 2026 FDA Inspections. All rights reserved.
Designed by Beybear

  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions
  • International Privacy / GDPR

Owned and operated by Global Regulatory LLC, Salt Lake City, Utah, USA. Independent consulting resource. Not affiliated with or endorsed by FDA.

Homepage consulting photograph: Alena Darmel / Pexels. Illustrative photography does not depict our team or clients.

Illustrative laboratory photograph: Rhoda Baer / National Cancer Institute, public domain. The photograph does not depict our personnel or a client facility.

Member templates · Redacted stories · Podcast · Free resources shop

Welcome Back

Sign in to access member resources, inspection tools and training.

Forgot your password?

New here? Create an account

Create Your Account

Set up an account to access member resources, inspection tools and training.

Already have an account? Log in

Reset your password

Enter your username or email and we will send you a link to set a new password.

Remembered it? Log in

FDA Inspection Alerts

Sign up for FDA inspection updates

Get practical notes on FDA 483s, Warning Letters, and inspection readiness.

Your cookie choices

Necessary storage supports sign-in, security, and store functions. Optional analytics helps us understand site use. Choose either option; member access does not require optional analytics. Cookie Policy · Privacy Policy